Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review

Document Sample
Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					               Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and
                            Strategic SWOT Analysis Review
        Reference Code: GDPH32903FSA                                                                                           Publication Date: JUL 2013

          3rd & 4th Floor, Batra Centre, 28,
                                                             Phone              +91 44 43446700                 Revenue           11,028.40 (million INR)
          Sardar Patel Road
          Chennai, Tamil Nadu                                Fax                +91 44 22350278                 Net Profit        530.40 (million INR)
          600032                                             Website            www.shasun.com                  Employees         1,500 (Estimated)
                                                                                SHASUNPHAR
                                                                                                                                  Pharmaceuticals          &
          India                                              Exchange           [National          Stock        Industry
                                                                                                                                  Healthcare
                                                                                Exchange of India]

       Company Overview
       Shasun Pharmaceuticals Limited (SPL) formerly Shasun Chemicals and Drugs Ltd., is a pharmaceutical company. It focuses on
       manufacturing active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients. The company's
       products indicated for treatment in therapeutic areas such as pain, musculoskeletal, hyperphosphataemia, central nervous
       system, cardiovascular, anti-infective, gastrointestinal and others. It also offers contract research, custom synthesis, contract
       manufacturing and contract formulation services. The company operates along with its subsidiaries in the US, Switzerland and
       India. SPL is headquartered in Chennai, Tamil Nadu, India.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Shasun Pharmaceuticals Limited, SWOT Analysis
         S. Abhaya Kumar                     Director                                 Strengths                              Weaknesses
         M. Mohan                            Director
                                                                                      Wide Geographical Coverage             Declining Cash Reserves
         Dr. S. Devendra                     Director
                                                                                      Broad Service and Solutions            Declining Profitability
         S. Vimal Kumar                      Director
                                                                                      Portfolio
         N. Subramanian                      Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Strategic Initiatives                  Inherent Market Factors
         Shasun Pharmaceuticals Limited
                                                                                      Growing Contract Research              Government Regulations
        Share Price (INR) as on 02-Jul-                                61.10          Organization Industry
        2013
        EPS (INR)                                                        9.61
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million INR)                                       3,417         GlobalData

        Enterprise Value (million INR)                                 7,712
        Shares Outstanding (million)                                       57
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Nov 02, 2012         Shasun Pharma Reports Revenue Of INR2.6
                                                                                                           Billion In Q2 Fiscal 2013
                                                                                      Aug 02, 2012         Shasun Pharma Reports Revenue Of INR2.5
                                                                                                           Billion In Q1 Fiscal 2013
                                                                                      Jun 18, 2012         Shasun Pharma To Setup Manufacturing
                                                                                                           Facility In Andhra Pradesh, India
                                                                                      May 24, 2012         Shasun Pharma Reports Revenue Of INR2.9
                                                                                                           Billion In Q4 Fiscal 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and                                                                    Reference Code: GDPH32903FSA
Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Shasun Pharmaceuticals Limited - Key Facts .................................................................................................................................... 4
       Shasun Pharmaceuticals Limited - Key Employees ........................................................................................................................... 5
       Shasun Pharmaceuticals Limited - Major Products and Services ...................................................................................................... 6
       Shasun Pharmaceuticals Limited - History ......................................................................................................................................... 8
       Shasun Pharmaceuticals Limited - Company Statement ................................................................................................................. 10
       Shasun Pharmaceuticals Limited - Locations And Subsidiaries ....................................................................................................... 11
          Head Office ................................................................................................................................................................................... 11
          Other Locations & Subsidiaries ..................................................................................................................................................... 11
       Section 2 – Company Analysis ......................................................................................................................................................... 13
       Shasun Pharmaceuticals Limited - Business Description ................................................................................................................. 13
       Shasun Pharmaceuticals Limited - Corporate Strategy .................................................................................................................... 14
       Shasun Pharmaceuticals Limited - SWOT Analysis ......................................................................................................................... 15
          SWOT Analysis - Overview........................................................................................................................................................... 15
          Shasun Pharmaceuticals Limited - Strengths ............................................................................................................................... 15
             Strength - Wide Geographical Coverage................................................................................................................................... 15
             Strength - Broad Service and Solutions Portfolio ...................................................................................................................... 15
             Strength - Bulk Active Pharmaceutical Ingredient Portfolio ....................................................................................................... 15
          Shasun Pharmaceuticals Limited - Weaknesses .......................................................................................................................... 16
             Weakness - Declining Cash Reserves ...................................................................................................................................... 16
             Weakness - Declining Profitability ............................................................................................................................................. 16
          Shasun Pharmaceuticals Limited - Opportunities ......................................................................................................................... 16
             Opportunity - Strategic Initiatives .............................................................................................................................................. 16
             Opportunity - Growing Contract Research Organization Industry ............................................................................................. 16
             Opportunity - Growth in Pharmaceutical Market........................................................................................................................ 17
             Opportunity - Biotech Focus ...................................................................................................................................................... 17
          Shasun Pharmaceuticals Limited - Threats .................................................................................................................................. 17
             Threat - In
				
DOCUMENT INFO
Description: Shasun Pharmaceuticals Limited (SHASUNPHAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Shasun Pharmaceuticals Limited (SPL) formerly Shasun Chemicals and Drugs Ltd.,
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.